ZBTB7C

gene
On this page

Also known as ZNF857C

Summary

ZBTB7C (zinc finger and BTB domain containing 7C, HGNC:31700) is a protein-coding gene on chromosome 18q21.1, encoding Zinc finger and BTB domain-containing protein 7C (A1YPR0). May be a tumor suppressor gene.

Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of cell population proliferation. Predicted to be located in nucleus.

Source: NCBI Gene 201501 — RefSeq curated summary.

At a glance

  • GWAS associations: 11
  • Clinical variants (ClinVar): 95 total
  • MANE Select transcript: NM_001318841

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31700
Approved symbolZBTB7C
Namezinc finger and BTB domain containing 7C
Location18q21.1
Locus typegene with protein product
StatusApproved
AliasesZNF857C
Ensembl geneENSG00000184828
Ensembl biotypeprotein_coding
OMIM616591
Entrez201501

Gene structure

Transcript identifiers

Ensembl transcripts: 38 — 38 protein_coding

ENST00000535628, ENST00000585404, ENST00000586047, ENST00000586438, ENST00000586525, ENST00000586743, ENST00000587107, ENST00000588028, ENST00000588053, ENST00000588149, ENST00000588566, ENST00000588970, ENST00000588982, ENST00000589077, ENST00000589170, ENST00000589194, ENST00000589619, ENST00000590178, ENST00000590374, ENST00000590437, ENST00000590800, ENST00000590855, ENST00000591279, ENST00000591405, ENST00000591526, ENST00000592387, ENST00000592656, ENST00000593159, ENST00000868923, ENST00000868924, ENST00000868925, ENST00000868926, ENST00000868927, ENST00000868928, ENST00000868929, ENST00000868930, ENST00000971936, ENST00000971937

RefSeq mRNA: 9 — MANE Select: NM_001318841 NM_001039360, NM_001318841, NM_001371284, NM_001371285, NM_001371286, NM_001371287, NM_001371288, NM_001371290, NM_001371291

CCDS: CCDS32830

Canonical transcript exons

ENST00000590800 — 5 exons

ExonStartEnd
ENSE000013077374803990048041123
ENSE000027443754818593448185995
ENSE000027937154833817448338398
ENSE000028744984840922648409383
ENSE000038443404802667248029911

Expression profiles

Bgee: expression breadth ubiquitous, 210 present calls, max score 90.15.

FANTOM5 (CAGE): breadth broad, TPM avg 2.1842 / max 131.8059, expressed in 472 samples.

FANTOM5 promoters (9 alternative TSS)

Promoter IDTPM avgSamples expressed
1718570.8969202
1718640.8940327
1718560.119560
1718620.096846
1718580.051028
1718610.044919
1718590.041621
1718600.033112
1718630.00644

Top tissues by expression

280 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mammalian vulvaUBERON:000099790.15gold quality
esophagus mucosaUBERON:000246990.02gold quality
bronchial epithelial cellCL:000232889.73gold quality
gingivaUBERON:000182889.71gold quality
lower esophagus mucosaUBERON:003583489.65gold quality
gingival epitheliumUBERON:000194989.48gold quality
esophagus squamous epitheliumUBERON:000692088.85gold quality
nippleUBERON:000203088.48gold quality
colonic mucosaUBERON:000031788.01gold quality
pharyngeal mucosaUBERON:000035587.52gold quality
oral cavityUBERON:000016787.51gold quality
mucosa of sigmoid colonUBERON:000499387.09gold quality
mucosa of transverse colonUBERON:000499186.33gold quality
mucosa of paranasal sinusUBERON:000503086.33silver quality
skin of legUBERON:000151185.71gold quality
sural nerveUBERON:001548885.62gold quality
upper leg skinUBERON:000426285.60gold quality
olfactory segment of nasal mucosaUBERON:000538684.99gold quality
corpus epididymisUBERON:000435984.85gold quality
skin of abdomenUBERON:000141684.65gold quality
zone of skinUBERON:000001484.37gold quality
calcaneal tendonUBERON:000370184.35gold quality
vaginaUBERON:000099684.00gold quality
right lobe of thyroid glandUBERON:000111983.96gold quality
left lobe of thyroid glandUBERON:000112083.81gold quality
thyroid glandUBERON:000204683.70gold quality
penisUBERON:000098983.69gold quality
adrenal tissueUBERON:001830383.07gold quality
right adrenal gland cortexUBERON:003582782.90gold quality
rectumUBERON:000105282.83gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-CURD-119yes25.90
E-ANND-3yes9.50

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

3 targets.

TargetRegulation
CDKN1AUnknown
FASN
NOTCH1

JASPAR motifs

MotifNameFamily
MA0695.1ZBTB7CMore than 3 adjacent zinc fingers
MA0695.2ZBTB7CMore than 3 adjacent zinc fingers
MA0695.3ZBTB7CMore than 3 adjacent zinc fingers

JASPAR matrix evidence (PMIDs): PMID:19443739

miRNA regulators (miRDB)

116 targeting ZBTB7C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-126-5P100.0072.713180
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-4747-5P100.0067.902681
HSA-MIR-5196-5P100.0067.982761
HSA-MIR-4476100.0068.182030
HSA-MIR-6876-5P100.0067.682126
HSA-MIR-3646100.0073.565283
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-5193100.0067.261744
HSA-MIR-366299.9973.825684
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-806899.9873.852376
HSA-MIR-448799.9664.581252
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-6755-5P99.9565.59464
HSA-MIR-545-3P99.9570.742783
HSA-MIR-449299.8768.253611
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-5010-3P99.8370.602357
HSA-MIR-6785-5P99.8268.684428

Literature-anchored findings (GeneRIF, showing 7)

  • Adm and APM-1 protect endothelium-dependent vascular relaxation in sepsis. (PMID:17932560)
  • our findings define KR-POK as a transcriptional repressor with a pro-oncogenic role that relies upon binding to p53 and inhibition of its transactivation function. (PMID:22253232)
  • ZBTB7C genetic variations were significant for susceptibility to ischemic injury in cerebral ischemia. (PMID:26542693)
  • Repression of Kr-POK inhibited tumor growth. (PMID:28571744)
  • Identification of Novel Alzheimer’s Disease Loci Using Sex-Specific Family-Based Association Analysis of Whole-Genome Sequence Data. (PMID:32193444)
  • The prognostic and immunological effects of ZBTB7C across cancers: friend or foe? (PMID:33946045)
  • ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression. (PMID:37121538)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriozbtb7cENSDARG00000100985
mus_musculusZbtb7cENSMUSG00000044646
rattus_norvegicusZbtb7cENSRNOG00000047924

Paralogs (36): ZBTB32 (ENSG00000011590), SNAI2 (ENSG00000019549), PRDM1 (ENSG00000057657), PRDM6 (ENSG00000061455), ZNF76 (ENSG00000065029), PATZ1 (ENSG00000100105), MAZ (ENSG00000103495), ZBTB16 (ENSG00000109906), ZNF451 (ENSG00000112200), ZBTB45 (ENSG00000119574), ZNF410 (ENSG00000119725), SNAI1 (ENSG00000124216), ZNF384 (ENSG00000126746), ZBTB1 (ENSG00000126804), VEZF1 (ENSG00000136451), PRDM14 (ENSG00000147596), ZNF276 (ENSG00000158805), ZNF362 (ENSG00000160094), ZNF653 (ENSG00000161914), ZNF281 (ENSG00000162702), ZNF148 (ENSG00000163848), ZNF143 (ENSG00000166478), HIC2 (ENSG00000169635), PRDM10 (ENSG00000170325), ZNF296 (ENSG00000170684), ZNF692 (ENSG00000171163), ZNF575 (ENSG00000176472), HIC1 (ENSG00000177374), ZBTB18 (ENSG00000179456), ZBTB42 (ENSG00000179627), ZBTB20 (ENSG00000181722), SNAI3 (ENSG00000185669), ZFP91 (ENSG00000186660), MTF1 (ENSG00000188786), SCRT2 (ENSG00000215397), SCRT1 (ENSG00000261678)

Protein

Protein identifiers

Zinc finger and BTB domain-containing protein 7CA1YPR0 (reviewed: A1YPR0)

Alternative names: Affected by papillomavirus DNA integration in ME180 cells protein 1, Zinc finger and BTB domain-containing protein 36, Zinc finger protein 857C

All UniProt accessions (6): A0A1B0GXF8, A1YPR0, B2RG49, B2RG53, B2RG63, B2RG76

UniProt curated annotations — full annotation on UniProt →

Function. May be a tumor suppressor gene.

Tissue specificity. Detected in normal cervical keratinocytes, and in some cervical carcinoma cell lines.

RefSeq proteins (9): NP_001034449, NP_001305770, NP_001358213, NP_001358214, NP_001358215, NP_001358216, NP_001358217, NP_001358219, NP_001358220 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000210BTB/POZ_domDomain
IPR011333SKP1/BTB/POZ_sfHomologous_superfamily
IPR013087Znf_C2H2_typeDomain
IPR016024ARM-type_foldHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050457ZnFinger_BTB_dom_containFamily

Pfam: PF00096, PF00651

UniProt features (9 total): zinc finger region 4, compositionally biased region 2, chain 1, domain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A1YPR0-F156.800.09

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 94 (showing top): GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION, GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION, GOBP_FAT_CELL_DIFFERENTIATION, CUI_TCF21_TARGETS_2_DN, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, DODD_NASOPHARYNGEAL_CARCINOMA_DN, chr18q21, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, PKCA_DN.V1_UP, ESC_J1_UP_EARLY.V1_UP, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY

GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of cell population proliferation (GO:0008285), positive regulation of fat cell differentiation (GO:0045600), positive regulation of transcription by RNA polymerase II (GO:0045944)

GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transcription by RNA polymerase II2
regulation of transcription by RNA polymerase II2
RNA polymerase II transcription regulatory region sequence-specific DNA binding2
regulation of DNA-templated transcription1
cell population proliferation1
regulation of cell population proliferation1
negative regulation of cellular process1
fat cell differentiation1
positive regulation of cell differentiation1
regulation of fat cell differentiation1
positive regulation of DNA-templated transcription1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

672 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZBTB7CMALRD1Q5VYJ5461
ZBTB7CCTIFO43310444
ZBTB7CCLIP3Q96DZ5443
ZBTB7CTP53P04637436
ZBTB7CCHST8Q9H2A9427
ZBTB7CCCDC60Q8IWA6413
ZBTB7CPHKBQ93100412
ZBTB7CADCY7P51828410
ZBTB7CPCF11O94913400
ZBTB7CCIDECQ96AQ7391
ZBTB7CAPLP1P51693387
ZBTB7CTHSD4Q6ZMP0383
ZBTB7CSLCO6A1Q86UG4376
ZBTB7CCSF2P04141375
ZBTB7CCXCL8P10145375
ZBTB7CRABEP2Q9H5N1375

IntAct

5 interactions, top by confidence:

ABTypeScore
RETREG1ZBTB7Cpsi-mi:“MI:0915”(physical association)0.370
HSCBRBP5psi-mi:“MI:0914”(association)0.350
ZBTB7CZBTB5psi-mi:“MI:0914”(association)0.350
CDC5Lpsi-mi:“MI:0914”(association)0.350

BioGRID (25): ZBTB7C (Affinity Capture-MS), JUN (Affinity Capture-Western), ZBTB7C (Affinity Capture-Western), JUN (Reconstituted Complex), ZBTB17 (Affinity Capture-Western), ZBTB7C (Reconstituted Complex), ZBTB17 (Reconstituted Complex), ZBTB7C (FRET), ZBTB7C (Affinity Capture-Western), PIAS1 (Affinity Capture-Western), ZBTB7C (Affinity Capture-Western), PIAS1 (Co-purification), ZBTB7C (Affinity Capture-MS), GATAD2B (Affinity Capture-MS), KLHL29 (Affinity Capture-MS)

ESM2 similar proteins: A0PJY2, A1YPR0, A2A935, B0K011, B0X9H6, B7ZRU9, O13089, O15090, O15156, O75626, O88939, O93567, O95365, P14404, P25932, P41183, P56260, Q03112, Q08DS3, Q0IHB8, Q1L8W0, Q2VWH6, Q32NK7, Q3T135, Q5XJQ7, Q60636, Q64321, Q6AY34, Q6DBW0, Q6F2E4, Q802Y8, Q8I7Z8, Q8K083, Q8N9L1, Q8NAP8, Q8TBJ5, Q8VCZ7, Q8VDL9, Q98T94, Q99PV8

Diamond homologs: A0A1B8YAB1, A1YPR0, B0WWP2, B1H285, B3M9V8, B3NDN0, B4GRJ2, B4HIK1, B4J045, B4L0G9, B4LIG6, B4MXW3, B4PD06, B4QLQ2, C9JR72, D3Z8N4, E0CZ16, G3X9X1, O15062, O88939, O93567, O95365, P28575, P41182, P41183, Q08CL3, Q08DK3, Q13105, Q16RL8, Q2M0J9, Q3UQV5, Q52KB5, Q5EXX3, Q5R7B8, Q5RDY3, Q5TC79, Q5ZI33, Q5ZKD9, Q5ZM39, Q60821

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

95 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance86
Likely benign2
Benign3

Top pathogenic / likely-pathogenic (0)

SpliceAI

1139 predictions. Top by Δscore:

VariantEffectΔscore
18:48029908:CTGC:Cacceptor_gain1.0000
18:48029909:TGC:Tacceptor_gain1.0000
18:48029910:GC:Gacceptor_gain1.0000
18:48029911:CC:Cacceptor_gain1.0000
18:48029912:C:CCacceptor_gain1.0000
18:48029917:A:ACacceptor_gain0.9900
18:48041119:GAGCC:Gacceptor_gain0.9900
18:48041121:GCC:Gacceptor_gain0.9900
18:48041122:CC:Cacceptor_gain0.9900
18:48041122:CCC:Cacceptor_gain0.9900
18:48041123:CC:Cacceptor_gain0.9900
18:48041123:CCTGC:Cacceptor_loss0.9900
18:48041124:C:CCacceptor_gain0.9900
18:48041124:CTG:Cacceptor_loss0.9900
18:48041125:T:Aacceptor_loss0.9900
18:48096670:A:ACdonor_gain0.9900
18:48096671:C:CCdonor_gain0.9900
18:48135812:T:TAdonor_gain0.9900
18:48029915:C:CTacceptor_gain0.9800
18:48029917:A:Cacceptor_gain0.9800
18:48041120:AGCC:Aacceptor_gain0.9800
18:48041135:C:CTacceptor_gain0.9800
18:48113646:T:Cacceptor_gain0.9800
18:48137002:CCCA:Cdonor_loss0.9800
18:48137003:CCA:Cdonor_loss0.9800
18:48137004:CAC:Cdonor_loss0.9800
18:48137006:C:CTdonor_loss0.9800
18:48029916:A:Tacceptor_gain0.9700
18:48041127:C:CTacceptor_gain0.9700
18:48072587:T:Cacceptor_gain0.9700

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000011 (18:48328680 C>T), RS1000011950 (18:48241047 C>A), RS1000012436 (18:48370657 GA>G,GAA), RS1000027935 (18:48117598 G>C,T), RS1000040228 (18:48041967 C>A), RS1000044048 (18:48191519 G>A), RS1000057599 (18:48083023 G>C), RS1000071026 (18:48123251 A>T), RS1000086384 (18:48109589 A>G,T), RS1000092841 (18:48237425 G>A), RS1000098980 (18:48295100 C>G,T), RS1000112532 (18:48072280 C>A), RS1000113216 (18:48100083 G>A), RS1000121744 (18:48205907 C>T), RS1000128659 (18:48164829 A>C)

Disease associations

OMIM: gene MIM:616591 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

11 associations (top):

StudyTraitp-value
GCST004025_6Systemic juvenile idiopathic arthritis6.000000e-07
GCST004749_49Lung cancer in ever smokers8.000000e-06
GCST006979_272Heel bone mineral density3.000000e-09
GCST006979_273Heel bone mineral density1.000000e-13
GCST007843_27Rheumatoid arthritis7.000000e-09
GCST008062_73Blood urea nitrogen levels2.000000e-14
GCST008152_187Weight9.000000e-06
GCST008758_75Pre-treatment viral load in HIV-1 infection5.000000e-16
GCST008839_255Height2.000000e-08
GCST010989_281Body size at age 102.000000e-21
GCST012145_10Ferritin levels6.000000e-06

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0009270heel bone mineral density
EFO:0004338body weight
EFO:0010125viral load
EFO:0009819comparative body size at age 10, self-reported
EFO:0004459ferritin measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression2
Benzo(a)pyreneaffects methylation, decreases methylation2
Valproic Acidincreases methylation, affects expression2
Aflatoxin B1increases methylation, decreases expression, decreases methylation2
perfluorotetradecanoic aciddecreases expression1
methyleugenoldecreases expression1
bisphenol Aaffects cotreatment, affects methylation, decreases methylation1
sodium arsenateincreases abundance, decreases expression1
beta-lapachonedecreases expression1
perfluorooctanoic acidaffects expression1
aflatoxin B2increases methylation1
perfluorobutyric aciddecreases expression1
CGP 52608affects binding, increases reaction1
Sunitinibdecreases expression1
Fulvestrantaffects cotreatment, affects methylation1
Arsenicdecreases expression, increases abundance1
Dichlorodiphenyl Dichloroethylenedecreases expression1
Doxorubicindecreases expression1
Estradiolaffects cotreatment, decreases expression1
Ethinyl Estradioldecreases expression1
Leadaffects expression1
Smokedecreases expression1
Triclosanincreases expression1
Okadaic Aciddecreases expression1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.